Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

‘Breakthrough’ startups reap investments from new early-stage fund

Wednesday, January 25th, 2012

Cambridge, Mass.-based Flagship Ventures recently launched the company's largest fund to date, raising $270 million for its life sciences funds, money that will add around 20 new biotechnology companies to Flagship's portfolio, according to officials. With the closing of the new fund, the company now has ...

   
©2012 UBM Canon